Clinical Trial Update: Rivaroxaban in Thrombotic Antiphospholipid Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update for rivaroxaban in antiphospholipid syndrome; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: University of Padova | Conditions: Antiphospholipid Syndrome | Phase 3 | Status: TERMINATED